CINVANTI®
Chemotherapy-Induced Nausea and Vomiting (CINV)
Key Facts
About Heron Therapeutics
Heron Therapeutics is a fully integrated biopharmaceutical company with a mission to improve patient lives through best-in-class, non-opioid medicines. The company has successfully commercialized a portfolio of four products targeting postoperative pain (ZYNRELEF®) and nausea/vomiting (SUSTOL®, CINVANTI®, APONVIE®), leveraging its proprietary Biochronomer® drug delivery technology to create sustained-release formulations. Its strategy focuses on addressing significant unmet needs in acute and oncology care by providing long-duration, localized therapy from a single administration, thereby reducing systemic side effects and healthcare burdens associated with opioid use and uncontrolled symptoms.
View full company profileTherapeutic Areas
Other Chemotherapy-Induced Nausea and Vomiting (CINV) Drugs
| Drug | Company | Phase |
|---|---|---|
| AKYNZEO® Oral Suspension | Helsinn | Approved |
| SUSTOL® | Heron Therapeutics | Approved |